TODAY'S HEADLINES
A new study provides the first mechanistic insight into the tumor-promoting role of chronic allergic contact dermatitis in skin cancer development. » See the study results
|
ADVERTISEMENT
Are your patients really following their treatment?
Patient adherence is as critical as it is often elusive. In this complimentary webinar, learn how doctor-patient trust can be transformed into treatment success and cost savings.
Click here for more
|
New results from a phase-3 study demonstrating the effect of Humira (adalimumab, AbbVie) in treating moderate-to-severe hidradenitis suppurativa (HS) may lead to worldwide regulatory filings for expanded use of the drug. » See the findings
|
ADVERTISEMENT
Best practices in the evaluation and management of actinic keratoses
Articles, video, tools and CME on current strategies for managing actinic keratoses lesions using a variety of therapeutic approaches based on efficacy, safety and tolerability.
Read More.
|
SIRT6, a protein that suppresses liver and colon tumor growth, seems to have the opposite effect on skin cancer when combined with sun exposure. »Read the findings
|
When evaluating teenagers for cosmetic procedures, it’s important to keep physical and emotional maturity in mind, experts say. » Read the suggestions
|
|
|